Seinda Corporation

Guangdong Seinda Biomedical Corporation (referred to as "Seinda Corporation") was established in 2015, focusing on point-of-care (POC) diagnostics for ophthalmic diseases. It has gathered experts from the fields of biomedicine, pharmaceuticals, immunology, and ophthalmology, possessing a globally competitive ophthalmic Biomarker research platform. It has designed and built the internationally leading, top-class domestic i-ImmunDx™ ophthalmic in vitro diagnostic analysis technology platform and POCT diagnostic reagent R&D technology platform.